Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Packard

Showing results (191-200 of 235) with videos related to

Pageof 24
Sort By:
Journal of Lipid Research|January 1, 1996
Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathwayJ Bjorkegren, C J Packard, A Hamsten, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|June 1, 1994
Determinants of LDL subfraction distribution and concentrations in young normolipidemic subjectsT D Watson, M J Caslake, D J Freeman, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 1, 1995
Relations between plasma lipids and postheparin plasma lipases and VLDL and LDL subfraction patterns in normolipemic men and womenC E Tan, L Foster, M J Caslake, et al.
British Medical Journal (Clinical Research Ed.)|July 19, 1986
Prevention of cardiovascular disease in general practice: a proposed modelE E Anggard, J M Land, C J Lenihan, et al.
European Journal of Clinical Investigation|December 1, 1992
Post-prandial lipoprotein metabolism in nephrotic syndromeG L Warwick, C J Packard, J P Stewart, et al.
Journal of Lipid Research|January 30, 1999
The apolipoprotein B R3531C mutation. Characteristics of 24 subjects from 9 kindredsC R Pullinger, D Gaffney, M M Gutierrez, et al.
Metabolism: Clinical and Experimental|February 1, 1989
Effect of combined therapy with bezafibrate and cholestyramine on low-density lipoprotein metabolism in type IIa hypercholesterolemiaJ J Series, M J Caslake, C Kilday, et al.
The American Journal of Clinical Nutrition|December 22, 2000
The coffee diterpene cafestol increases plasma triacylglycerol by increasing the production rate of large VLDL apolipoprotein B in healthy normolipidemic subjectsB de Roos, M J Caslake, A F Stalenhoef, et al.
Lipids|June 1, 1980
Abnormal suppression of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by hypertriglyceridemic very low density lipoprotein subclassesS H Gianturco, C J Packard, J Shepherd, et al.
Scottish Medical Journal|April 1, 1995
Heart and arterial disease risk factor levels in the Scottish workforce: cross-sectional study of risk factor levels. The SHARP Committee. Scottish Heart and Arterial Disease Risk PreventionS R McEwan, P Arthur, M H Shamssain, et al.
Pageof 24

Showing results (191-200 of 235) with videos related to

Sort By:
Pageof 24
Journal of Lipid Research|January 1, 1996
Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathwayJ Bjorkegren, C J Packard, A Hamsten, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|June 1, 1994
Determinants of LDL subfraction distribution and concentrations in young normolipidemic subjectsT D Watson, M J Caslake, D J Freeman, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 1, 1995
Relations between plasma lipids and postheparin plasma lipases and VLDL and LDL subfraction patterns in normolipemic men and womenC E Tan, L Foster, M J Caslake, et al.
British Medical Journal (Clinical Research Ed.)|July 19, 1986
Prevention of cardiovascular disease in general practice: a proposed modelE E Anggard, J M Land, C J Lenihan, et al.
European Journal of Clinical Investigation|December 1, 1992
Post-prandial lipoprotein metabolism in nephrotic syndromeG L Warwick, C J Packard, J P Stewart, et al.
Journal of Lipid Research|January 30, 1999
The apolipoprotein B R3531C mutation. Characteristics of 24 subjects from 9 kindredsC R Pullinger, D Gaffney, M M Gutierrez, et al.
Metabolism: Clinical and Experimental|February 1, 1989
Effect of combined therapy with bezafibrate and cholestyramine on low-density lipoprotein metabolism in type IIa hypercholesterolemiaJ J Series, M J Caslake, C Kilday, et al.
The American Journal of Clinical Nutrition|December 22, 2000
The coffee diterpene cafestol increases plasma triacylglycerol by increasing the production rate of large VLDL apolipoprotein B in healthy normolipidemic subjectsB de Roos, M J Caslake, A F Stalenhoef, et al.
Lipids|June 1, 1980
Abnormal suppression of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by hypertriglyceridemic very low density lipoprotein subclassesS H Gianturco, C J Packard, J Shepherd, et al.
Scottish Medical Journal|April 1, 1995
Heart and arterial disease risk factor levels in the Scottish workforce: cross-sectional study of risk factor levels. The SHARP Committee. Scottish Heart and Arterial Disease Risk PreventionS R McEwan, P Arthur, M H Shamssain, et al.
Pageof 24